A Study of Ladiratuzumab Vedotin in Advanced Solid Tumors
Public ClinicalTrials.gov record NCT04032704. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Open-Label Phase 2 Study of Ladiratuzumab Vedotin (LV) for Unresectable Locally Advanced or Metastatic Solid Tumors
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This trial will study ladiratuzumab vedotin (LV) alone and with pembrolizumab to find out if it works to treat different types of solid tumors. It will also find out what side effects may occur. A side effect is anything the drug does besides treating cancer.
Study identification
- NCT ID
- NCT04032704
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 205 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 9, 2019 (Actual)
- Primary completion
- Nov 28, 2023 (Actual)
- Completion
- Nov 28, 2023 (Actual)
- Last update posted
- Mar 10, 2025
2019 – 2023
United States locations
- U.S. sites
- 27
- U.S. states
- 21
- U.S. cities
- 27
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Ironwood Cancer & Research Centers - Chandler | Chandler | Arizona | 85224 | — |
| Adventist Health White Memorial | Los Angeles | California | 90033 | — |
| Providence Medical Foundation | Santa Rosa | California | 95403 | — |
| Eastern CT Hematology and Oncology Associates | Norwich | Connecticut | 06360 | — |
| GenesisCare USA | Jacksonville | Florida | 32204 | — |
| AdventHealth Cancer Institute | Orlando | Florida | 32804 | — |
| IACT Health | Columbus | Georgia | 31904 | — |
| Northwestern University | Chicago | Illinois | 60611 | — |
| Decatur Memorial Hospital - Illinois | Decatur | Illinois | 62526 | — |
| Fort Wayne Medical Oncology and Hematology | Fort Wayne | Indiana | 46804 | — |
| University of Maryland | Baltimore | Maryland | 21201 | — |
| University of Michigan Comprehensive Cancer Center | Ann Arbor | Michigan | 48109 | — |
| HealthPartners Institute | Saint Louis Park | Minnesota | 55416 | — |
| Comprehensive Cancer Centers of Nevada | Las Vegas | Nevada | 89169 | — |
| Valley Hospital, The / Luckow Pavilion | Paramus | New Jersey | 07652 | — |
| San Juan Oncology Associates | Farmington | New Mexico | 87401 | — |
| Weill Cornell Medicine | New York | New York | 10065 | — |
| Stony Brook University Cancer Center | Stony Brook | New York | 11794-7263 | — |
| FirstHealth of the Carolinas | Pinehurst | North Carolina | 28374 | — |
| Gabrail Cancer Center Research, LLC | Canton | Ohio | 44718 | — |
| Providence Portland Medical Center | Portland | Oregon | 97213 | — |
| Saint Francis Hospital / Bon Secours - South Carolina | Greenville | South Carolina | 29601 | — |
| Erlanger Oncology and Hematology | Chattanooga | Tennessee | 37403 | — |
| Tennessee Oncology-Nashville/Sarah Cannon Research Institute | Nashville | Tennessee | 37203 | — |
| Joe Arrington Cancer Research and Treatment Center | Lubbock | Texas | 79410 | — |
| UT Health East Texas Hope Cancer Center | Tyler | Texas | 75701 | — |
| Carbone Cancer Center / University of Wisconsin | Madison | Wisconsin | 53792 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 39 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04032704, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 10, 2025 · Synced Oct 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04032704 live on ClinicalTrials.gov.